China NMPA Product Recall - Trifecta Valve, a bioartificial heart valve with Glide Technology;

On August 29, 2023, St. Jude Medical, in collaboration with Abbott Medical Products (Shanghai) Co., Ltd., announced a voluntary recall of specific bioartificial heart valves within its Trifecta series. This significant action was taken due to St. Jude Medical's strategic decision to cease the sale of these particular valve products and to initiate the revocation of their CE certification. The recall primarily affects the Trifecta Valve with Glide Technology, identified by National Medical Device Registration Certificate 20213130259, and the Trifecta Valve, associated with National Medical Device Registration Certificate 20183461040. The National Medical Products Administration (NMPA) document outlines this event, emphasizing that the recall level is separate, with comprehensive details regarding affected models, specifications, and batches provided in an attached Medical Device Recall Event Report Form. This recall is a proactive measure by the manufacturer to manage its product line, indicating a business decision to withdraw these devices from the market rather than an immediate safety violation stemming from an inspection. While no specific inspection dates are mentioned, the NMPA's publication confirms the regulatory oversight. The required action involves the systematic voluntary recall of all specified Trifecta series heart valves to ensure their removal from circulation, aligning with regulatory expectations for product discontinuation.